"Breakthrough Blood Test Identifies 18 Early Cancers with 93% Accuracy"

US researchers have developed a new DNA test that can analyze proteins in the blood to detect 18 different types of early-stage cancers across major human organs with high accuracy. This multi-screening test has the potential to reshape cancer screening guidelines and become a standard part of routine check-ups, potentially leading to improved treatment and higher survival rates. The test, developed by the US biotech firm Novelna, outperforms previous methods and could help diagnose pre-cancerous and early-stage cancer before significant damage occurs, although further studies are needed to establish its effectiveness.